Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021
Abstract Background Direct-acting antivirals (DAAs) for hepatitis C treatment in China became available since 2017. This study expects to generate evidence to inform decision-making in a nationwide scale-up of DAA treatment in China. Methods We described the number of standard DAA treatment at both...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |